David Paul Fredrickson serves as Executive at Caris Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, David Paul Fredrickson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 26, 2026 involved receiving (via award) 2,492 shares valued at $50.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | CAI | $50.0K | Award | 2,492 | $20.06 | Discretionary |
David Paul Fredrickson currently holds 18,621 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Paul Fredrickson has been a net neutral trader of CAI stock. They have purchased $0 and sold $0 worth of shares.
David Paul Fredrickson's most recent insider trade was on Feb 26, 2026, when they sold 2,492 shares at $20.06 per share.
Get notified when new Form 4 filings are submitted